Fresenius And Formycon File Ustekinumab In Europe

Application For FYB202 Biosimilar Rival To Stelara Is Accepted By EMA

 
• By David Wallace
  
EMA
The ustekinumab filing has been accepted by the EMA
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products